{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:55:25Z","timestamp":1787320525295,"version":"build-2736575974"},"reference-count":58,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,12,17]],"date-time":"2012-12-17T00:00:00Z","timestamp":1355702400000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:p>Myasthenia gravis with antibodies to muscle\u2010specific tyrosine kinase (MuSK\u2010MG) is generally considered a severe disease because of the associated weakness distribution with prevalent involvement of bulbar muscles and a rapidly progressive course and early respiratory crises. Its treatment can be unrewarding, owing to poor response to acetylcholinesterase inhibitors in most patients, disease relapses in spite of high\u2010dose immunosuppression, and development of permanent bulbar weakness. High\u2010dose prednisone plus plasma exchange is the recommended approach for treating rapidly progressive bulbar weakness. In the disease management, oral steroids proved effective, plasma exchange produced marked, albeit short\u2010term, improvement, while conventional immunosuppressants were comparatively less effective. Rituximab is a promising treatment for refractory MuSK\u2010MG; in uncontrolled studies, nearly all treated patients achieved significant improvement with substantial decrease of medication. It is yet to be clarified whether the early use of rituximab could prevent the permanent bulbar weakness, which constitutes a relevant disability in these patients.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2012.06781.x","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T14:02:49Z","timestamp":1355839369000},"page":"86-91","source":"Crossref","is-referenced-by-count":29,"title":["Management challenges in muscle\u2010specific tyrosine kinase myasthenia gravis"],"prefix":"10.1111","volume":"1274","author":[{"given":"Amelia","family":"Evoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo E.","family":"Alboini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Bisonni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Mastrorosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Bartocccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,12,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg223"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000150587.71497.B6"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20386"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000183145.91579.74"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri916"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20061"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2011.12.005"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.052415"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000254620.45529.97"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e32833c0982"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1405.012"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0032-8"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21533"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2008.02176.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2009.03.020"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.10.031"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2011.04.018"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.1.16"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22006"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20491"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2009.5.2.53"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000065882.63904.53"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0b013e318137a24b"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20411"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-006-0442-2"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000254617.15644.f4"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.135319"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000228225.23349.5d"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01870.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.01.013"},{"key":"e_1_2_6_32_2","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar involvement in MuSK antibody\u2010associated myasthenia gravis","volume":"129","author":"Farrugia M.E.","year":"2006","journal-title":"Brain"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6569.2009.00456.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2011.01.010"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.171793"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2008.08.011"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318237f660"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.3109\/08916930903518107"},{"key":"e_1_2_6_39_2","first-page":"A299","article-title":"Muscle antibody positive myasthenia gravis: response to treatment in 31 patients","volume":"68","author":"Sanders D.B.","year":"2007","journal-title":"Neurology (asbtract)"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.05.032"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410410615"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.05.065"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2007.00877.x"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10400"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1405.033"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00945.x"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.197632"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182407982"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20479"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.093567"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0b013e3181fcc109"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2008.02399.x"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21521"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756285611411503"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0b013e3181df2b3e"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2010.220475"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.07.032"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1104650"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.27435"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2012.06781.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2012.06781.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:18:44Z","timestamp":1695003524000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2012.06781.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/j.1749-6632.2012.06781.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06781.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}